CTOs on the Move

TrueCore Behavioral Solutions

www.truecorebehavioral.com

 
Tampa, Florida-based TrueCore Behavioral Solutions operates residential facilities for youth who have been ordered by the court into juvenile justice facilities. The company has a 20-year history of providing services to at-risk youth, helping young people discover their true core potential to lead productive and rewarding lives. Today, nearly 2,000 TrueCore professionals and staff in facilities across four states offer vital services and support, including alternative education schools and programs for vocational training, substance abuse recovery, behavioral and mental health, and sexual offender treatment.
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Future Health Concepts Inc

Future Health Concepts Inc is a Sanford, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Plasmatech Biopharmaceuticals

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.

Queensland Health

Queensland Health is the states largest healthcare provider, committed to ensuring all Queenslanders have access to a range of public healthcare services aimed at achieving good health and well being.

RediClinic LLC

RediClinic LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Houston, TX. To find more information about RediClinic LLC, please visit www.rediclinic.com

Sarepta

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.